)
Silgan (SLGN) investor relations material
Silgan Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved record or near-record adjusted earnings, free cash flow, and segment profitability in 2025, returning $160 million to shareholders and reducing leverage to target range post-Weener acquisition.
Successfully integrated Weener acquisition, completed multi-year cost savings program, and outpaced market in target organic growth products and end markets.
Dispensing and Specialty Closures and Metal Containers delivered record sales, EBIT, and EBITDA, with margin expansion and strong growth in pet food and fragrance/beauty.
Net sales reached $6.5 billion in 2025, up 11% year-over-year, with net income of $288.4 million ($2.70 per diluted share).
Free cash flow for 2025 was $445.2 million, a 14% increase from 2024.
Financial highlights
Q4 2025 net sales of ~$1.5 billion, up 4% year-over-year; full-year net sales $6.5 billion, up 11%.
Q4 adjusted EBIT $150.6 million, flat year-over-year; adjusted EPS $0.67, down $0.18 due to higher interest and tax.
Full-year 2025 adjusted EPS $3.72, up 3% over 2024; 2026 guidance $3.70–$3.90.
Free cash flow for 2026 estimated at $450 million; CapEx guidance $310 million, focused on dispensing and pet food growth.
Adjusted EBITDA for 2025 was $977.8 million, up from $881.5 million in 2024.
Outlook and guidance
2026 adjusted EBIT and EBITDA expected to exceed 2025 levels at midpoint of guidance.
2026 adjusted net income per diluted share projected at $3.70–$3.90, a 2% increase at midpoint over 2025.
Dispensing and Specialty Closures organic volumes to grow low to mid-single digits; Metal Containers volumes to grow low single digits, led by pet food.
Q1 2026 adjusted EPS guidance $0.70–$0.80 (vs. $0.82 prior year), reflecting prior year inventory benefits.
Interest expense to rise to ~$205 million in 2026 due to note maturity; tax rate 25–26%.
- TimeTickerHeadlineOpen
- KE
Medical sales surged 15% in Q2 2026 as guidance for sales and margins was raised. - GL
Earnings and sales grew across all segments, with higher 2026 guidance and ongoing share buybacks. - RSI
Record financial results, all motions passed, and LEAP project remains a strategic priority. - COST
January sales climbed 9.3% to $21.33B, with digital sales up 34.4%. - FR
FFO per share rose 11.7% in 2025, with robust rental growth and a higher dividend. - ALCO
Land sales and leasing drove improved profitability and strong liquidity as citrus operations ended. - PAHC
Net sales and profit surged on acquisition, with raised outlook and strong liquidity. - PTC
Q1'26 saw double-digit growth, margin gains, and major share repurchases, with a strong FY'26 outlook. - MKL
Operating income rose to $3.2B, with broad-based growth and improved insurance profitability. - UHAL
Q3 net loss of $37M on higher costs and depreciation, but self-storage revenue increased.
Next Silgan earnings date
Next Silgan earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)